We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mobile 3-in-1 Imaging System Advances Intraoperative Navigation

By HospiMedica International staff writers
Posted on 09 Sep 2026

Globus Medical’s Excelsius3D intelligent 3-in-1 imaging system has received the CE Mark for commercial sale in the European Union and the United Kingdom. More...

The addition of Excelsius3D expands the company’s Excelsius Ecosystem of enabling technologies and enhances the capabilities of the ExcelsiusGPS robotic navigation system in Europe. The system is intended to support a connected platform for intraoperative imaging and guidance.

Excelsius3D is an intelligent, mobile imaging platform that combines 3D cone‑beam computed tomography (CT), 2D fluoroscopy, and digital radiography in a single system. Designed for intraoperative use, it integrates with ExcelsiusGPS so intraoperative imaging and robotic navigation work together within a streamlined procedural workflow. A compact footprint and omnidirectional wheels facilitate positioning and transport in the operating room while offering multiple imaging modalities in one platform.

Indications for use specify that Excelsius3D is a mobile X‑ray system designed for 2D fluoroscopy, 2D digital radiography, and 3D imaging of adult and pediatric patients. It is intended for situations in which physicians benefit from 2D and 3D information on anatomic structures and on high‑contrast, high‑attenuation objects such as bony anatomy and metallic objects. Acquired images are compatible with image‑guided systems such as ExcelsiusGPS.

With CE marking, commercialization of Excelsius3D will begin in the European Union and United Kingdom. The system previously received U.S. Food and Drug Administration (FDA) 510(k) clearance in 2021. As part of the Excelsius Ecosystem, it can function as a stand‑alone intraoperative imaging platform or as an integrated component working with ExcelsiusGPS.

“The CE mark for Excelsius3D represents an important milestone in the continued expansion of the Excelsius Ecosystem. We are committed to bringing innovative enabling technologies to surgeons around the world, and this important milestone further expands the capabilities of our platform by combining intraoperative imaging with the robotic navigation capabilities of ExcelsiusGPS across the European Union,” said Keith Pfeil, President and Chief Executive Officer of Globus Medical.

Related Links
Globus Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Immobilization System
Cranial 4Pi Immobilization
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.